Ridgefield, CT, United States of America

Jeroen Van Beek


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jeroen Van Beek: Innovator in Mental Health Treatments

Introduction

Jeroen Van Beek is a notable inventor based in Ridgefield, CT, who has made significant contributions to the field of mental health treatments. With a focus on innovative pharmaceutical solutions, he holds two patents that address critical mental health disorders.

Latest Patents

His latest patents include methods for the treatment of social anxiety disorder. The invention provides methods for treating this condition by administering specific compounds, including 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone or its pharmaceutically acceptable salts. Additionally, he has developed methods for treating obsessive-compulsive disorder, which involve administering a related compound, showcasing his commitment to advancing mental health therapies.

Career Highlights

Jeroen Van Beek is currently associated with Indevus Pharmaceuticals, Inc., where he continues to work on innovative treatments. His expertise in pharmacology and dedication to improving patient outcomes have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

He collaborates with esteemed colleagues, including Cathryn M Clary and Perry S Eisman, to further enhance the development of effective treatments for mental health disorders.

Conclusion

Jeroen Van Beek's contributions to the field of mental health through his patents and work at Indevus Pharmaceuticals highlight his role as an influential inventor. His innovative approaches to treating social anxiety and obsessive-compulsive disorders reflect a commitment to improving the lives of those affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…